Portal hypertension increases the risk of hepatic decompensation after 90Yttrium radioembolization in patients with hepatocellular carcinoma: a cohort study

BACKGROUND: Transarterial radioembolization (TARE) is increasingly used in patients with hepatocellular carcinoma (HCC). This treatment can induce or impair portal hypertension, leading to hepatic decompensation. TARE also promotes changes in liver and spleen volumes that may modify therapeutic deci...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrión, Laura, Clemente-Sánchez, Ana, Márquez-Pérez, Laura, Orcajo-Rincón, Javier, Rotger, Amanda, Ramón-Botella, Enrique, González-Leyte, Manuel, Echenagusía-Boyra, Miguel, Luis Colón, Arturo, Reguera-Berenguer, Laura, Bañares, Rafael, Rincón, Diego, Matilla-Peña, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619355/
https://www.ncbi.nlm.nih.gov/pubmed/37920686
http://dx.doi.org/10.1177/17562848231206995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619355/
https://www.ncbi.nlm.nih.gov/pubmed/37920686
http://dx.doi.org/10.1177/17562848231206995

Ejemplares similares